Comment on " Atorvastatin improves disease activity of nonalcoholic steatohepatitis partly through its tumour necrosis factor-α-lowering property"

Digestive and Liver Disease

Volumn 45, Issue 1, 2013, Pages 81-82

  Angelico, Francesco ^a   Del Ben, Maria ^a   Pignatelli, Pasquale ^a   Violi, Francesco ^a  

^a SAPIENZA UNIVERSITY OF ROME   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

ADIPONECTIN; AMINOTRANSFERASE; ATORVASTATIN; ISOPROSTANE DERIVATIVE; PITAVASTATIN; REACTIVE OXYGEN METABOLITE; REDUCED NICOTINAMIDE ADENINE DINUCLEOTIDE PHOSPHATE OXIDASE; ROSUVASTATIN; SIMVASTATIN; TUMOR NECROSIS FACTOR ALPHA;

AMINOTRANSFERASE BLOOD LEVEL; ATHEROSCLEROSIS; CARDIOVASCULAR DISEASE; CHOLESTEROL BLOOD LEVEL; CYTOKINE PRODUCTION; DISEASE ACTIVITY; DISEASE ASSOCIATION; DISEASE COURSE; DRUG EFFECT; DYSLIPIDEMIA; HUMAN; HYPERCHOLESTEROLEMIA; INSULIN RESISTANCE; LETTER; LIPID PEROXIDATION; LIPID STORAGE; LIVER BIOPSY; LIVER HISTOLOGY; LOW DRUG DOSE; NONALCOHOLIC FATTY LIVER; OXIDATIVE STRESS; PATHOGENESIS; PRIORITY JOURNAL; THROMBOCYTE; TREATMENT DURATION;

ANTICHOLESTEREMIC AGENTS; DYSLIPIDEMIAS; FATTY LIVER; FEMALE; HEPTANOIC ACIDS; HUMANS; MALE; PYRROLES; TUMOR NECROSIS FACTOR-ALPHA;

EID: 84871622463     PISSN: 15908658     EISSN: 18783562     Source Type: Journal    
DOI: 10.1016/j.dld.2012.07.009     Document Type: Letter

References (5)

1. Hyogo H., Yamagishi S., Maeda S., et al. Atorvastatin improves disease activity of nonalcoholic steatohepatitis partly through its tumour necrosis factor-α-lowering property. Digestive and Liver Disease 2012, 44:492-496.
2. Nakahara T., Hyogo H., Kimura Y., et al. Efficacy of rosuvastatin for the treatment of non-alcoholic steatohepatitis with dyslipidemia: an open-label, pilot study. Hepatology Research 2012, (April). [Epub ahead of print]. 10.1111/j.1872-034X.2012.01034.x.
3. Hyogo H., Ikegami T., Tokushige K., et al. Efficacy of pitavastatin for the treatment of non-alcoholic steatohepatitis with dyslipidemia: an open-label, pilot study. Hepatology Research 2011, 41:1057-1065.
4. Nelson A., Torres D.M., Morgan A.E., et al. A pilot study using simvastatin in the treatment of nonalcoholic steatohepatitis: a randomized placebo-controlled trial. Journal of Clinical Gastroenterology 2009, 43:990-994.
5. Carnevale R., Pignatelli P., Di Santo S., et al. Atorvastatin inhibits oxidative stress via adiponectin-mediated NADPH oxidase down-regulation in hypercholesterolemic patients. Atherosclerosis 2010, 213:225-234.